Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-08-02
2005-08-02
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S085700, C424S085400, C530S351000, C514S002600, C514S021800, C514S894000, C536S028600, C536S028700
Reexamination Certificate
active
06924270
ABSTRACT:
Ribavirin derivatives represented by the formula II, pharmaceutical compositions containing them as well as methods of using the ribavirin derivatives represented by the formula II for the treatment of susceptible viral infections, for example, chronic hepatitis C infections administrating, the ribavirin derivatives being represented by formula IIare disclosed.
REFERENCES:
patent: 6277830 (2001-08-01), Ganguly et al.
Bennett Frank
Ganguly Ashit K.
Girijavallabhan Viyyoor M.
Lovey Raymond G.
Mc Cormick Jinping
Hoffman Thomas D.
Lewis Patrick
Schering Corporation
Wilson James O.
LandOfFree
Ribavirin-interferon alfa combination therapy for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ribavirin-interferon alfa combination therapy for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ribavirin-interferon alfa combination therapy for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3471841